CN Stock MarketDetailed Quotes

300110 Huaren Pharmaceutical

Watchlist

3.47
+0.11+3.27%

Trading Jan 6 14:27 CST

4.10BMarket Cap27.98P/E (TTM)

Huaren Pharmaceutical Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

Assets

Current assets

Money funds

-40.02%120.1M

-67.20%114.51M

-50.47%112.16M

4.66%232.04M

42.12%200.23M

18.00%349.09M

-35.25%226.47M

-46.85%221.71M

-75.03%140.89M

-30.39%295.85M

Notes receivable and accounts receivable

-10.03%584.56M

-8.33%612.48M

-2.35%664.63M

2.75%656.37M

-15.56%649.72M

-15.25%668.12M

-16.10%680.65M

-20.82%638.77M

-24.65%769.46M

-4.21%788.34M

-Notes receivable

-52.78%989.06K

-6.90%1.4M

0.44%1.43M

-21.35%1.64M

-35.95%2.09M

-9.76%1.51M

-45.11%1.42M

-44.19%2.08M

--3.27M

--1.67M

-Accounts receivable

-9.89%583.57M

-8.33%611.08M

-2.36%663.2M

2.83%654.73M

-15.47%647.63M

-15.26%666.62M

-16.01%679.23M

-20.71%636.69M

-24.97%766.19M

-4.42%786.67M

Other receivables (including interest and dividends)

-2.53%1.37B

-3.37%1.37B

-4.30%1.37B

-4.52%1.36B

13.07%1.41B

14.75%1.42B

16.19%1.43B

0.71%1.43B

8.83%1.24B

17.47%1.24B

-Other receivable

----

-3.37%1.37B

----

14.75%1.42B

----

0.71%1.43B

----

17.47%1.24B

Advance payment

-44.47%47.53M

-42.80%59.83M

-48.11%40.28M

-37.33%38.52M

-23.28%85.58M

-18.50%104.59M

-32.08%77.63M

-33.05%61.47M

12.99%111.55M

34.99%128.33M

Inventories

-9.24%310.69M

7.18%319.07M

30.97%319.19M

25.40%334.63M

14.60%342.32M

9.17%297.68M

-4.54%243.72M

-3.13%266.85M

-0.92%298.72M

-6.71%272.68M

Receivable financing

-11.90%86.25M

79.14%139.09M

50.56%112.52M

49.06%149.74M

-4.11%97.89M

-30.31%77.64M

-3.78%74.73M

24.60%100.46M

-0.61%102.09M

-7.77%111.4M

Other current assets

-0.01%19.72M

-3.39%15.07M

14.57%15.04M

37.69%15.99M

99.10%19.72M

43.16%15.6M

38.28%13.13M

-33.52%11.61M

1,583.12%9.91M

650.97%10.89M

Total current assets

-9.36%2.54B

-10.25%2.63B

-4.15%2.63B

2.27%2.79B

4.68%2.8B

3.08%2.93B

-3.57%2.75B

-12.17%2.73B

-17.19%2.68B

1.19%2.84B

Non Current assets

Other equity investment

0.00%15.98M

Investment real estate

-3.05%9.17M

-3.02%9.24M

-3.00%9.32M

-2.98%9.39M

-4.37%9.46M

-2.94%9.53M

-2.91%9.6M

-2.89%9.68M

--9.89M

--9.82M

Fixed assets

----

-2.17%1.04B

----

-7.93%1.06B

----

-7.92%1.11B

----

-5.99%1.15B

Constru in process

----

37.90%49.53M

----

146.37%35.92M

----

203.35%23.36M

----

47.92%14.58M

Intangible assets

-3.29%307.73M

-3.99%310.5M

-3.93%313.81M

-3.99%318.53M

-7.23%318.19M

-8.94%323.4M

-9.46%326.65M

-9.39%331.77M

-7.72%343M

135.33%355.13M

Development expenditure

-61.14%8.73M

-33.79%11.65M

-15.41%13.46M

3.94%13.04M

141.08%22.46M

71.53%17.59M

136.55%15.92M

159.27%12.55M

154.22%9.32M

626.40%10.25M

Goodwill

-0.76%820.04M

-0.04%826.29M

0.00%826.64M

191.44%826.64M

Long deferred expense

-18.65%12.87M

-6.98%11.43M

-2.91%13.52M

9.96%16.05M

16.21%15.82M

-15.95%12.29M

-4.58%13.92M

-17.78%14.6M

-36.19%13.61M

-41.24%14.62M

Deferred tax assets

-31.58%42.48M

-27.58%43.18M

-26.50%42.98M

-26.09%42.03M

19.72%62.09M

21.82%59.62M

24.47%58.48M

22.56%56.87M

29.52%51.86M

26.56%48.94M

Usufruct assets

-69.70%383.26K

-68.03%487.79K

-30.38%910.83K

-31.00%1.06M

-28.60%1.26M

92.38%1.53M

26.57%1.31M

19.98%1.53M

--1.77M

--792.99K

Other non current assets

65.30%38.06M

70.77%38.2M

57.84%40.56M

-12.38%23.34M

0.43%23.03M

-2.04%22.37M

7.96%25.7M

-2.11%26.64M

-21.08%22.93M

-12.30%22.83M

Total non current assets

-1.56%2.33B

-1.57%2.35B

-0.95%2.37B

-2.42%2.37B

-2.79%2.37B

-3.50%2.39B

-4.13%2.39B

-3.97%2.43B

-4.39%2.44B

39.07%2.47B

Total assets

-5.78%4.87B

-6.35%4.98B

-2.66%5B

0.06%5.17B

1.12%5.17B

0.02%5.32B

-3.83%5.14B

-8.49%5.16B

-11.55%5.11B

15.88%5.32B

Liabilities

Current liabilities

Short term loan

-36.97%420.06M

-52.56%415.99M

-55.21%453.34M

-48.72%624.83M

-44.97%666.44M

-37.50%876.83M

-29.68%1.01B

-22.83%1.22B

-27.68%1.21B

3.03%1.4B

Notes payable and accounts payable

-9.72%114.14M

8.25%154.05M

5.55%132.17M

15.94%142.32M

-10.36%126.43M

2.56%142.31M

-2.88%125.22M

-3.41%122.75M

-1.20%141.05M

-9.71%138.76M

-Accounts payable

-9.72%114.14M

8.25%154.05M

5.55%132.17M

15.94%142.32M

-10.36%126.43M

2.56%142.31M

-2.88%125.22M

-3.41%122.75M

-1.20%141.05M

-9.71%138.76M

Contract liabilities

57.96%36.76M

9.38%35.36M

27.16%40.16M

73.61%55.55M

-29.99%23.27M

-10.24%32.33M

24.59%31.58M

13.59%32M

51.02%33.24M

98.28%36.02M

Salaries payable

-14.75%15.67M

-26.22%14.97M

19.55%16.94M

82.32%22.99M

9.40%18.39M

33.54%20.29M

38.23%14.17M

-12.97%12.61M

78.71%16.81M

102.78%15.2M

Taxs payable

-58.69%18.16M

-22.98%21.14M

-54.16%22.02M

-58.53%32.39M

-34.28%43.95M

-52.78%27.44M

-13.28%48.04M

60.77%78.11M

15.98%66.88M

35.23%58.11M

Other payable (including interest and dividends)

-17.45%209.84M

-15.31%234.83M

11.47%234.37M

1.15%212.54M

24.99%254.19M

15.23%277.29M

-10.29%210.26M

-63.11%210.12M

-81.86%203.37M

-54.25%240.65M

-Dividend payable

----

--24.83M

----

-Other payable

----

-6.99%234.83M

----

4.91%252.46M

----

-63.11%210.12M

----

-54.25%240.65M

Non current liabilities due within one year

-0.45%604.73M

10.90%633.77M

70.58%626.69M

19.57%420M

74.41%607.45M

73.82%571.48M

40.07%367.4M

59.36%351.26M

1,168.39%348.3M

13,051.15%328.78M

Other current liabilities

57.96%4.78M

9.38%4.6M

27.16%5.22M

35.29%5.65M

-29.99%3.03M

-10.24%4.2M

4.38%4.11M

16.27%4.18M

51.02%4.32M

98.28%4.68M

Total current liabilities

-18.30%1.42B

-22.41%1.51B

-15.56%1.53B

-25.29%1.52B

-13.92%1.74B

-12.27%1.95B

-16.06%1.81B

-21.67%2.03B

-33.77%2.03B

5.22%2.23B

Current liabilities

Long term loan

-14.90%566.68M

-7.90%605.34M

20.12%605.86M

137.12%836.42M

86.13%665.88M

61.12%657.28M

49.21%504.4M

53.13%352.74M

53.85%357.75M

609.46%407.94M

Long term account payable

----

-59.70%128M

----

--128M

Long term salaries pay

----

--0

----

68.50%855.64K

--507.81K

Deferred tax liabilities

-7.59%44.44M

-6.16%45.2M

-7.56%45.96M

-8.27%46.72M

-8.77%48.09M

-11.00%48.17M

-9.64%49.72M

-8.84%50.93M

-9.45%52.71M

128.30%54.12M

Long term deferred income

-20.00%175.41K

-75.67%175.41K

-82.69%219.27K

-87.60%219.27K

-90.34%219.27K

-73.99%720.93K

-68.68%1.27M

-55.93%1.77M

Lease liabilities

--0

-63.65%145.93K

-60.20%163.08K

-48.38%428.93K

--1.02M

--401.42K

55.03%409.74K

--830.93K

----

Total non current liabilities

-14.56%611.29M

-8.03%650.72M

-4.60%652.14M

65.55%883.48M

32.23%715.47M

19.45%707.54M

-4.18%683.59M

-12.14%533.66M

83.54%541.06M

595.08%592.34M

Total liabilities

-17.21%2.04B

-18.58%2.17B

-12.56%2.18B

-6.37%2.4B

-4.19%2.46B

-5.60%2.66B

-13.11%2.5B

-19.86%2.56B

-23.46%2.57B

28.06%2.82B

Shareholders equity

Paid-in capital

0.00%1.18B

Capital reserve funds

0.00%528.04M

Surplus reserve funds

9.75%84.62M

9.74%84.62M

7.69%77.1M

7.70%77.11M

6.84%71.6M

Retained profit

13.34%969.92M

18.31%947.6M

21.08%950.04M

20.95%899.22M

23.77%855.79M

24.70%800.98M

27.68%784.63M

26.12%743.49M

19.02%691.43M

19.57%642.31M

Shareholders equity without minority interests

4.60%2.76B

5.96%2.74B

6.72%2.74B

6.45%2.69B

6.87%2.64B

6.77%2.59B

7.33%2.57B

6.73%2.53B

4.88%2.47B

4.74%2.42B

Minority interests

3.38%72.44M

3.41%71M

5.41%73.42M

4.33%71.86M

-6.76%70.07M

-7.24%68.66M

-4.89%69.65M

-4.45%68.88M

5.08%75.15M

1.54%74.02M

Total shareholder equity

4.57%2.84B

5.89%2.81B

6.69%2.82B

6.39%2.77B

6.47%2.71B

6.36%2.66B

6.97%2.64B

6.40%2.6B

4.88%2.55B

4.64%2.5B

Total liabilityies and equity

-5.78%4.87B

-6.35%4.98B

-2.66%5B

0.06%5.17B

1.12%5.17B

0.02%5.32B

-3.83%5.14B

-8.49%5.16B

-11.55%5.11B

15.88%5.32B

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

ZTE Accounting firm (Special General Partnership)

	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022
Assets
Current assets
Money funds	-40.02%120.1M	-67.20%114.51M	-50.47%112.16M	4.66%232.04M	42.12%200.23M	18.00%349.09M	-35.25%226.47M	-46.85%221.71M	-75.03%140.89M	-30.39%295.85M
Notes receivable and accounts receivable	-10.03%584.56M	-8.33%612.48M	-2.35%664.63M	2.75%656.37M	-15.56%649.72M	-15.25%668.12M	-16.10%680.65M	-20.82%638.77M	-24.65%769.46M	-4.21%788.34M
-Notes receivable	-52.78%989.06K	-6.90%1.4M	0.44%1.43M	-21.35%1.64M	-35.95%2.09M	-9.76%1.51M	-45.11%1.42M	-44.19%2.08M	--3.27M	--1.67M
-Accounts receivable	-9.89%583.57M	-8.33%611.08M	-2.36%663.2M	2.83%654.73M	-15.47%647.63M	-15.26%666.62M	-16.01%679.23M	-20.71%636.69M	-24.97%766.19M	-4.42%786.67M
Other receivables (including interest and dividends)	-2.53%1.37B	-3.37%1.37B	-4.30%1.37B	-4.52%1.36B	13.07%1.41B	14.75%1.42B	16.19%1.43B	0.71%1.43B	8.83%1.24B	17.47%1.24B
-Other receivable	----	-3.37%1.37B	----	----	----	14.75%1.42B	----	0.71%1.43B	----	17.47%1.24B
Advance payment	-44.47%47.53M	-42.80%59.83M	-48.11%40.28M	-37.33%38.52M	-23.28%85.58M	-18.50%104.59M	-32.08%77.63M	-33.05%61.47M	12.99%111.55M	34.99%128.33M
Inventories	-9.24%310.69M	7.18%319.07M	30.97%319.19M	25.40%334.63M	14.60%342.32M	9.17%297.68M	-4.54%243.72M	-3.13%266.85M	-0.92%298.72M	-6.71%272.68M
Receivable financing	-11.90%86.25M	79.14%139.09M	50.56%112.52M	49.06%149.74M	-4.11%97.89M	-30.31%77.64M	-3.78%74.73M	24.60%100.46M	-0.61%102.09M	-7.77%111.4M
Other current assets	-0.01%19.72M	-3.39%15.07M	14.57%15.04M	37.69%15.99M	99.10%19.72M	43.16%15.6M	38.28%13.13M	-33.52%11.61M	1,583.12%9.91M	650.97%10.89M
Total current assets	-9.36%2.54B	-10.25%2.63B	-4.15%2.63B	2.27%2.79B	4.68%2.8B	3.08%2.93B	-3.57%2.75B	-12.17%2.73B	-17.19%2.68B	1.19%2.84B
Non Current assets
Other equity investment	0.00%15.98M	0.00%15.98M	0.00%15.98M	0.00%15.98M	0.00%15.98M	0.00%15.98M	0.00%15.98M	0.00%15.98M	0.00%15.98M	0.00%15.98M
Investment real estate	-3.05%9.17M	-3.02%9.24M	-3.00%9.32M	-2.98%9.39M	-4.37%9.46M	-2.94%9.53M	-2.91%9.6M	-2.89%9.68M	--9.89M	--9.82M
Fixed assets	----	-2.17%1.04B	----	----	----	-7.93%1.06B	----	-7.92%1.11B	----	-5.99%1.15B
Constru in process	----	37.90%49.53M	----	----	----	146.37%35.92M	----	203.35%23.36M	----	47.92%14.58M
Intangible assets	-3.29%307.73M	-3.99%310.5M	-3.93%313.81M	-3.99%318.53M	-7.23%318.19M	-8.94%323.4M	-9.46%326.65M	-9.39%331.77M	-7.72%343M	135.33%355.13M
Development expenditure	-61.14%8.73M	-33.79%11.65M	-15.41%13.46M	3.94%13.04M	141.08%22.46M	71.53%17.59M	136.55%15.92M	159.27%12.55M	154.22%9.32M	626.40%10.25M
Goodwill	-0.76%820.04M	-0.76%820.04M	-0.76%820.04M	-0.76%820.04M	-0.04%826.29M	-0.04%826.29M	-0.04%826.29M	-0.04%826.29M	0.00%826.64M	191.44%826.64M
Long deferred expense	-18.65%12.87M	-6.98%11.43M	-2.91%13.52M	9.96%16.05M	16.21%15.82M	-15.95%12.29M	-4.58%13.92M	-17.78%14.6M	-36.19%13.61M	-41.24%14.62M
Deferred tax assets	-31.58%42.48M	-27.58%43.18M	-26.50%42.98M	-26.09%42.03M	19.72%62.09M	21.82%59.62M	24.47%58.48M	22.56%56.87M	29.52%51.86M	26.56%48.94M
Usufruct assets	-69.70%383.26K	-68.03%487.79K	-30.38%910.83K	-31.00%1.06M	-28.60%1.26M	92.38%1.53M	26.57%1.31M	19.98%1.53M	--1.77M	--792.99K
Other non current assets	65.30%38.06M	70.77%38.2M	57.84%40.56M	-12.38%23.34M	0.43%23.03M	-2.04%22.37M	7.96%25.7M	-2.11%26.64M	-21.08%22.93M	-12.30%22.83M
Total non current assets	-1.56%2.33B	-1.57%2.35B	-0.95%2.37B	-2.42%2.37B	-2.79%2.37B	-3.50%2.39B	-4.13%2.39B	-3.97%2.43B	-4.39%2.44B	39.07%2.47B
Total assets	-5.78%4.87B	-6.35%4.98B	-2.66%5B	0.06%5.17B	1.12%5.17B	0.02%5.32B	-3.83%5.14B	-8.49%5.16B	-11.55%5.11B	15.88%5.32B
Liabilities
Current liabilities
Short term loan	-36.97%420.06M	-52.56%415.99M	-55.21%453.34M	-48.72%624.83M	-44.97%666.44M	-37.50%876.83M	-29.68%1.01B	-22.83%1.22B	-27.68%1.21B	3.03%1.4B
Notes payable and accounts payable	-9.72%114.14M	8.25%154.05M	5.55%132.17M	15.94%142.32M	-10.36%126.43M	2.56%142.31M	-2.88%125.22M	-3.41%122.75M	-1.20%141.05M	-9.71%138.76M
-Accounts payable	-9.72%114.14M	8.25%154.05M	5.55%132.17M	15.94%142.32M	-10.36%126.43M	2.56%142.31M	-2.88%125.22M	-3.41%122.75M	-1.20%141.05M	-9.71%138.76M
Contract liabilities	57.96%36.76M	9.38%35.36M	27.16%40.16M	73.61%55.55M	-29.99%23.27M	-10.24%32.33M	24.59%31.58M	13.59%32M	51.02%33.24M	98.28%36.02M
Salaries payable	-14.75%15.67M	-26.22%14.97M	19.55%16.94M	82.32%22.99M	9.40%18.39M	33.54%20.29M	38.23%14.17M	-12.97%12.61M	78.71%16.81M	102.78%15.2M
Taxs payable	-58.69%18.16M	-22.98%21.14M	-54.16%22.02M	-58.53%32.39M	-34.28%43.95M	-52.78%27.44M	-13.28%48.04M	60.77%78.11M	15.98%66.88M	35.23%58.11M
Other payable (including interest and dividends)	-17.45%209.84M	-15.31%234.83M	11.47%234.37M	1.15%212.54M	24.99%254.19M	15.23%277.29M	-10.29%210.26M	-63.11%210.12M	-81.86%203.37M	-54.25%240.65M
-Dividend payable	----	----	----	----	----	--24.83M	----	----	----	----
-Other payable	----	-6.99%234.83M	----	----	----	4.91%252.46M	----	-63.11%210.12M	----	-54.25%240.65M
Non current liabilities due within one year	-0.45%604.73M	10.90%633.77M	70.58%626.69M	19.57%420M	74.41%607.45M	73.82%571.48M	40.07%367.4M	59.36%351.26M	1,168.39%348.3M	13,051.15%328.78M
Other current liabilities	57.96%4.78M	9.38%4.6M	27.16%5.22M	35.29%5.65M	-29.99%3.03M	-10.24%4.2M	4.38%4.11M	16.27%4.18M	51.02%4.32M	98.28%4.68M
Total current liabilities	-18.30%1.42B	-22.41%1.51B	-15.56%1.53B	-25.29%1.52B	-13.92%1.74B	-12.27%1.95B	-16.06%1.81B	-21.67%2.03B	-33.77%2.03B	5.22%2.23B
Current liabilities
Long term loan	-14.90%566.68M	-7.90%605.34M	20.12%605.86M	137.12%836.42M	86.13%665.88M	61.12%657.28M	49.21%504.4M	53.13%352.74M	53.85%357.75M	609.46%407.94M
Long term account payable	----	----	----	----	----	----	----	-59.70%128M	----	--128M
Long term salaries pay	----	----	--0	----	68.50%855.64K	68.50%855.64K	68.50%855.64K	68.50%855.64K	--507.81K	--507.81K
Deferred tax liabilities	-7.59%44.44M	-6.16%45.2M	-7.56%45.96M	-8.27%46.72M	-8.77%48.09M	-11.00%48.17M	-9.64%49.72M	-8.84%50.93M	-9.45%52.71M	128.30%54.12M
Long term deferred income	-20.00%175.41K	-20.00%175.41K	-20.00%175.41K	-75.67%175.41K	-82.69%219.27K	-87.60%219.27K	-90.34%219.27K	-73.99%720.93K	-68.68%1.27M	-55.93%1.77M
Lease liabilities	--0	--0	-63.65%145.93K	-60.20%163.08K	-48.38%428.93K	--1.02M	--401.42K	55.03%409.74K	--830.93K	----
Total non current liabilities	-14.56%611.29M	-8.03%650.72M	-4.60%652.14M	65.55%883.48M	32.23%715.47M	19.45%707.54M	-4.18%683.59M	-12.14%533.66M	83.54%541.06M	595.08%592.34M
Total liabilities	-17.21%2.04B	-18.58%2.17B	-12.56%2.18B	-6.37%2.4B	-4.19%2.46B	-5.60%2.66B	-13.11%2.5B	-19.86%2.56B	-23.46%2.57B	28.06%2.82B
Shareholders equity
Paid-in capital	0.00%1.18B	0.00%1.18B	0.00%1.18B	0.00%1.18B	0.00%1.18B	0.00%1.18B	0.00%1.18B	0.00%1.18B	0.00%1.18B	0.00%1.18B
Capital reserve funds	0.00%528.04M	0.00%528.04M	0.00%528.04M	0.00%528.04M	0.00%528.04M	0.00%528.04M	0.00%528.04M	0.00%528.04M	0.00%528.04M	0.00%528.04M
Surplus reserve funds	9.75%84.62M	9.75%84.62M	9.75%84.62M	9.74%84.62M	7.69%77.1M	7.69%77.1M	7.69%77.1M	7.70%77.11M	6.84%71.6M	6.84%71.6M
Retained profit	13.34%969.92M	18.31%947.6M	21.08%950.04M	20.95%899.22M	23.77%855.79M	24.70%800.98M	27.68%784.63M	26.12%743.49M	19.02%691.43M	19.57%642.31M
Shareholders equity without minority interests	4.60%2.76B	5.96%2.74B	6.72%2.74B	6.45%2.69B	6.87%2.64B	6.77%2.59B	7.33%2.57B	6.73%2.53B	4.88%2.47B	4.74%2.42B
Minority interests	3.38%72.44M	3.41%71M	5.41%73.42M	4.33%71.86M	-6.76%70.07M	-7.24%68.66M	-4.89%69.65M	-4.45%68.88M	5.08%75.15M	1.54%74.02M
Total shareholder equity	4.57%2.84B	5.89%2.81B	6.69%2.82B	6.39%2.77B	6.47%2.71B	6.36%2.66B	6.97%2.64B	6.40%2.6B	4.88%2.55B	4.64%2.5B
Total liabilityies and equity	-5.78%4.87B	-6.35%4.98B	-2.66%5B	0.06%5.17B	1.12%5.17B	0.02%5.32B	-3.83%5.14B	-8.49%5.16B	-11.55%5.11B	15.88%5.32B
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--
Auditor	--	--	--	ZTE Accounting firm (Special General Partnership)	--	--	--	ZTE Accounting firm (Special General Partnership)	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List

Overall

No Data

Investment Theme

Pharmaceutical E-commerce

300110 Huaren Pharmaceutical

Huaren Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow